1-204424895-G-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001377334.1(PIK3C2B):āc.4862C>Gā(p.Thr1621Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000318 in 1,614,208 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Synonymous variant affecting the same amino acid position (i.e. T1621T) has been classified as Likely benign.
Frequency
Consequence
NM_001377334.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIK3C2B | NM_001377334.1 | c.4862C>G | p.Thr1621Ser | missense_variant | 33/33 | ENST00000684373.1 | NP_001364263.1 | |
PIK3C2B | NM_002646.4 | c.4862C>G | p.Thr1621Ser | missense_variant | 35/35 | NP_002637.3 | ||
PIK3C2B | NM_001377335.1 | c.4778C>G | p.Thr1593Ser | missense_variant | 36/36 | NP_001364264.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIK3C2B | ENST00000684373.1 | c.4862C>G | p.Thr1621Ser | missense_variant | 33/33 | NM_001377334.1 | ENSP00000507222.1 |
Frequencies
GnomAD3 genomes AF: 0.00158 AC: 241AN: 152208Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000402 AC: 101AN: 251226Hom.: 1 AF XY: 0.000228 AC XY: 31AN XY: 135812
GnomAD4 exome AF: 0.000185 AC: 270AN: 1461882Hom.: 2 Cov.: 31 AF XY: 0.000151 AC XY: 110AN XY: 727240
GnomAD4 genome AF: 0.00160 AC: 243AN: 152326Hom.: 2 Cov.: 32 AF XY: 0.00141 AC XY: 105AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 10, 2018 | - - |
PIK3C2B-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 25, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at